<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03334630</url>
  </required_header>
  <id_info>
    <org_study_id>TP00599</org_study_id>
    <nct_id>NCT03334630</nct_id>
  </id_info>
  <brief_title>DiamondTemp™ Ablation System for the Treatment of Paroxysmal Atrial Fibrillation</brief_title>
  <acronym>DIAMOND-AF</acronym>
  <official_title>A Randomized Controlled Clinical Evaluation of the DiamondTemp™ System for the Treatment of Paroxysmal Atrial Fibrillation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Advanced Cardiac Therapeutics</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Advanced Cardiac Therapeutics</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the DIAMOND-AF study is to establish the safety and effectiveness of the
      DiamondTemp System for the treatment of drug refractory, recurrent, symptomatic paroxysmal
      atrial fibrillation in patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The DIAMOND-AF study is a prospective, single blind, 1:1 randomized controlled study being
      performed at multiple centers in the United States, Canada and Europe. The study will
      evaluate the safety and effectiveness of the DiamondTemp System used for ablation in patients
      with paroxysmal atrial fibrillation (AF). Subjects will be randomized for treatment with
      either the DiamondTemp Ablation Catheter or the TactiCath™ Quartz Contact Force Ablation
      Catheter manufactured by Abbott. Patients will be followed for 12 months.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 6, 2017</start_date>
  <completion_date type="Anticipated">April 2020</completion_date>
  <primary_completion_date type="Anticipated">December 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of Device Related Serious Adverse Events measured at 30 days in all subjects</measure>
    <time_frame>30 days after index ablation procedure</time_frame>
    <description>Freedom from a Composite of Pre-Specified Serious Adverse Events</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The Rate of Subjects Who Were Free From Documented Symptomatic Atrial Fibrillation (AF), Atrial Tachycardia (AT), or Atrial Flutter (AFL) Episodes Through 12-month Follow-up</measure>
    <time_frame>3-12 months after index ablation procedure</time_frame>
    <description>The primary effectiveness endpoint for this study will be freedom from documented symptomatic AF, AFL, AT</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">480</enrollment>
  <condition>Paroxysmal Atrial Fibrillation</condition>
  <condition>Atrial Fibrillation</condition>
  <arm_group>
    <arm_group_label>DiamondTemp Ablation Catheter</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Catheter ablation to treat paroxysmal atrial fibrillation using temperature-controlled ablation catheter</description>
  </arm_group>
  <arm_group>
    <arm_group_label>TactiCath Quartz Ablation Catheter</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Catheter ablation to treat atrial fibrillation using contact-force sensing ablation catheter</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>DiamondTemp Ablation catheter</intervention_name>
    <description>a pulmonary vein isolation procedure will be performed using radiofrequency ablation catheter</description>
    <arm_group_label>DiamondTemp Ablation Catheter</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>TactiCath Quartz Ablation catheter</intervention_name>
    <description>a pulmonary vein isolation procedure will be performed using radiofrequency ablation catheter</description>
    <arm_group_label>TactiCath Quartz Ablation Catheter</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Key Inclusion Criteria:

          -  Above 18 years of age

          -  Subjects with a history of symptomatic, paroxysmal atrial fibrillation (PAF) who have
             had ≥ 2 episodes of PAF reported within the 12 months prior to index ablation
             procedure

          -  At least one episode of PAF documented by electrocardiographic data within 12 months
             prior to index ablation procedure and a physician's note indicating recurrent
             self-terminating AF

          -  Failure or intolerance of at least one Class I-IV anti-arrhythmic AAD for treatment of
             PAF

        Exclusion Criteria:

          -  LA diameter &gt; 5.5 cm

          -  Left ventricular ejection fraction &lt; 35%

          -  Currently NYHA Class III or IV or exhibits uncontrolled heart failure

          -  Myocardial infarction, unstable angina, cardiac surgery or coronary intervention
             within 3 months of the ablation procedure

          -  Documented stroke, CVA, TIA or suspected neurological event within 6 months of the
             ablation procedure
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Josef Kautzner, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Institut klinické a experimentální medicíny (IKEM)</affiliation>
  </overall_official>
  <overall_official>
    <last_name>William Maddox, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Alabama at Birmingham</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Tom McElderry, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Alabama at Birmingham</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Bryan Wylie</last_name>
    <phone>+1 (408) 477-7575</phone>
    <email>info@diamond-af.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Patty Hevey</last_name>
    <phone>+1 (408) 477-7538</phone>
    <email>info@diamond-af.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Alabama at Birmingham</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35294</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michelle Blue, RN</last_name>
      <phone>205-975-4336</phone>
      <email>mblue@uabmc.edu</email>
    </contact>
    <investigator>
      <last_name>Will Maddox, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Tom McElderry, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Massachusetts General Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02114</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Grace Ha, MS</last_name>
    </contact>
    <investigator>
      <last_name>Moussa Mansour, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Jackson Heart Clinic</name>
      <address>
        <city>Jackson</city>
        <state>Mississippi</state>
        <zip>39216</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lisa Milner, RN</last_name>
      <phone>601-982-7850</phone>
      <email>lmilner@jacksonheart.com</email>
    </contact>
    <investigator>
      <last_name>Judson Colley III, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Icahn School of Medicine at Mount Sinai</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10029</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Betsy Ellsworth, MSN, ANP</last_name>
      <phone>212-824-8902</phone>
      <email>betsy.ellsworth@mountsinai.org</email>
    </contact>
    <investigator>
      <last_name>Srinivas Dukkipati, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Vivek Reddy, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jacob Koruth, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>William Whang, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Trident Medical Center</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <zip>29406</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tim Buck</last_name>
      <email>Tim.Buck@hcahealthcare.com</email>
    </contact>
    <investigator>
      <last_name>Darren Sidney, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Frank Cuoco, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Medical University of South Carolina</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <zip>29425</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Debi Everdige, RN</last_name>
      <phone>843-792-2944</phone>
      <email>adamsde@musc.edu</email>
    </contact>
    <investigator>
      <last_name>Frank Cuoco, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Texas Cardiac Arrhythmia Research Foundation</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78705</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Deb Cardinal</last_name>
      <phone>512-458-9410</phone>
      <email>dscardinal@austinheartbeat.com</email>
    </contact>
    <investigator>
      <last_name>Amin Al-Ahmad, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Andrea Natale, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>David Burkhardt, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jason Zagrodzky, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Houston Methodist Research Institute</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Michelle L Prystash, RN</last_name>
      <email>mlprystash@houstonmethodist.org</email>
    </contact>
    <investigator>
      <last_name>Miguel Valderrabano, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. Ann's University Hospital</name>
      <address>
        <city>Brno</city>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alice Vybíralová, RN</last_name>
      <email>alice.vybiralova@fnusa.cz</email>
    </contact>
    <investigator>
      <last_name>Zdeněk Stárek, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Na Homolce</name>
      <address>
        <city>Prague</city>
        <zip>15000</zip>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Na Homolce</name>
      <address>
        <city>Prague</city>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Katerina Mzourkova, RN</last_name>
      <phone>+420 606 532 420</phone>
      <email>katerina.mzourkova@homolka.cz</email>
    </contact>
    <investigator>
      <last_name>Jan Petru, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Institut Klinické a Experimentální Medicíny (IKEM)</name>
      <address>
        <city>Praha</city>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tereza Nováková, RN</last_name>
      <email>novt@ikem.cz</email>
    </contact>
    <investigator>
      <last_name>Josef Kautzner, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Petr Peichl, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinique du Tonkin</name>
      <address>
        <city>Villeurbanne</city>
        <state>Lyon</state>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rafik Stiti, RN</last_name>
      <phone>+33 6 12 08 22 60</phone>
    </contact>
    <investigator>
      <last_name>Herve Poty, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHRU de Nancy</name>
      <address>
        <city>Nancy</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Véronique Midenet, RN</last_name>
      <email>v.midenet@chru-nancy.fr</email>
    </contact>
    <investigator>
      <last_name>Christian de Chillou, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinique Pasteur</name>
      <address>
        <city>Toulouse</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Juliette Goutner, RN</last_name>
      <phone>+ 33 6 13 73 18 38</phone>
      <email>jgcardioconsult@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Jean Paul Albenque, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Serge Boveda, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centro Cardiologico Monzino</name>
      <address>
        <city>Milan</city>
        <state>Milano</state>
        <zip>20138</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Selene Celluci, BSc</last_name>
      <phone>+39 02 58002506</phone>
    </contact>
    <investigator>
      <last_name>Claudio Tondo, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Czechia</country>
    <country>France</country>
    <country>Italy</country>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Iwasawa J, Koruth JS, Petru J, Dujka L, Kralovec S, Mzourkova K, Dukkipati SR, Neuzil P, Reddy VY. Temperature-Controlled Radiofrequency Ablation for Pulmonary Vein Isolation in Patients With Atrial Fibrillation. J Am Coll Cardiol. 2017 Aug 1;70(5):542-553. doi: 10.1016/j.jacc.2017.06.008.</citation>
    <PMID>28750697</PMID>
  </reference>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 24, 2017</study_first_submitted>
  <study_first_submitted_qc>November 3, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">November 7, 2017</study_first_posted>
  <last_update_submitted>May 14, 2018</last_update_submitted>
  <last_update_submitted_qc>May 14, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 16, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>ablation</keyword>
  <keyword>electrophysiology</keyword>
  <keyword>atrial fibrillation</keyword>
  <keyword>catheter</keyword>
  <keyword>paroxysmal</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

